A. Taşatargil Et Al. , "Poly(ADP-Ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta," PHARMACOLOGY , vol.72, no.2, pp.99-105, 2004
Taşatargil, A. Et Al. 2004. Poly(ADP-Ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta. PHARMACOLOGY , vol.72, no.2 , 99-105.
Taşatargil, A., Dalaklioglu, S., & Şadan, G., (2004). Poly(ADP-Ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta. PHARMACOLOGY , vol.72, no.2, 99-105.
Taşatargil, ARDA, SELVİNAZ TAŞATARGİL, And Gülay Şadan. "Poly(ADP-Ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta," PHARMACOLOGY , vol.72, no.2, 99-105, 2004
Taşatargil, ARDA Et Al. "Poly(ADP-Ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta." PHARMACOLOGY , vol.72, no.2, pp.99-105, 2004
Taşatargil, A. Dalaklioglu, S. And Şadan, G. (2004) . "Poly(ADP-Ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta." PHARMACOLOGY , vol.72, no.2, pp.99-105.
@article{article, author={ARDA TAŞATARGİL Et Al. }, title={Poly(ADP-Ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta}, journal={PHARMACOLOGY}, year=2004, pages={99-105} }